Understanding Your Lung Scans and Breathing Tests
At a Glance
For rheumatoid arthritis-associated interstitial lung disease, HRCT shows patterns of inflammation and scarring such as UIP or NSIP, while pulmonary function tests measure lung performance. FVC and DLCO results, followed over time, help doctors assess severity and change.
Diagnosing RA-ILD is a complex process that combines high-tech imaging with specialized breathing tests. Because the lungs and the joints are both involved, your care team uses these tools to create a “phenotype”—a detailed picture of exactly how the disease is behaving in your specific body [1].
The Recommended Expert Approach: High-Resolution CT (HRCT)
A standard chest X-ray is often not detailed enough to see the fine changes of interstitial lung disease. Instead, doctors use High-Resolution Computed Tomography (HRCT), which takes very thin “slices” of lung images to provide a clear view of the interstitium (the delicate tissue between the air sacs) [2][3].
When a radiologist looks at your HRCT, they are searching for specific patterns that help predict how the disease might progress:
- UIP (Usual Interstitial Pneumonia): This pattern is characterized by scarring that usually starts at the bottom and outer edges of the lungs [4]. It is often associated with a higher risk of a more persistent course of the disease, though it does not guarantee rapid progression [5].
- NSIP (Nonspecific Interstitial Pneumonia): This pattern often looks more like “ground-glass,” which can sometimes indicate a different balance of inflammation versus scarring that may respond differently to treatment [4][6].
- Other Patterns: You might also see terms like Organizing Pneumonia (OP) or “indeterminate,” which mean the pattern doesn’t perfectly fit one category yet [7].
Decoding Your HRCT Report
Your report may contain technical terms that describe the type of changes in your lung tissue:
- Honeycombing: These are small, clustered air cysts that look like a honeycomb on the scan [8]. They represent areas of established, permanent scarring (fibrosis) [9].
- Traction Bronchiectasis: This occurs when thick scar tissue pulls on the bronchi (airways), stretching them open wider than they should be [8].
- Ground-Glass Opacity: This looks like a hazy, gray area on the scan (similar to looking through a frosted window). It can reflect inflammation, fine fibrosis, active infection, or fluid buildup (edema) [10].
- Reticulation: A network of fine lines seen on the scan, often indicating early thickening or scarring of the interstitium.
Measuring Function: Pulmonary Function Tests (PFTs)
While the HRCT shows what the lungs look like, Pulmonary Function Tests (PFTs) measure how well they actually work [11]. Two numbers are particularly important and are evaluated as a “percent predicted” based on your age, height, and sex:
- FVC (Forced Vital Capacity): This is the total amount of air you can breathe out after taking the deepest breath possible [12]. If your lungs are stiff from scarring, they cannot hold as much air, and your FVC will drop [3].
- DLCO (Diffusing Capacity of the Lung for Carbon Monoxide): This test measures how easily a surrogate gas travels from your air sacs into your bloodstream [5]. DLCO is often very sensitive, but it can also be affected by hemoglobin levels (anemia), emphysema, or pulmonary vascular disease [12].
The Multidisciplinary Team
Because RA-ILD sits at the intersection of two different medical specialties, the recommended expert approach for an accurate diagnosis is a Multidisciplinary Discussion (MDD) [13]. This is a formal meeting where your pulmonologist (lung doctor), rheumatologist (joint doctor), and a radiologist (imaging expert) review your scans, history, and tests together [14]. This team approach is essential because lung changes in RA can sometimes be caused by things other than ILD, such as a side effect of a medication or a past infection [15][16].
Completeness Checklist: Your HRCT Report
When you receive your imaging report, check to see if it includes these key details. If it doesn’t, you may want to ask your doctor for more specifics:
- [ ] Pattern Identification: Does it mention UIP, NSIP, or another specific pattern?
- [ ] Presence of Fibrosis: Does it explicitly state if honeycombing or traction bronchiectasis is present?
- [ ] Distribution: Does it note if the changes are mostly in the lower lungs or spread throughout?
- [ ] Comparison: Does the report compare the new scan to any older ones to check for changes?
- [ ] Alternative Findings: Does it mention other issues like emphysema or signs of heart failure?
Common questions in this guide
Why is an HRCT scan used to evaluate RA-ILD?
What do UIP and NSIP mean on an RA-ILD scan?
What do honeycombing and traction bronchiectasis mean on a CT scan?
What do FVC and DLCO show on pulmonary function tests?
Who should review my RA-ILD scans and breathing tests?
What if my breathing feels worse even though my PFT results are stable?
Get notified when new evidence is published on rheumatoid arthritis-associated interstitial lung disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (16)
- 1
Rheumatoid arthritis related interstitial lung disease.
Manfredi A, Cassone G, Luppi F, et al.
Expert review of clinical immunology 2021; (17(5)):485-497 doi:10.1080/1744666X.2021.1905524.
PMID: 33779447 - 2
The role of lung ultrasound B-lines and serum KL-6 in the screening and follow-up of rheumatoid arthritis patients for an identification of interstitial lung disease: review of the literature, proposal for a preliminary algorithm, and clinical application to cases.
Wang Y, Chen S, Zheng S, et al.
Arthritis research & therapy 2021; (23(1)):212 doi:10.1186/s13075-021-02586-9.
PMID: 34391465 - 3
Rheumatoid arthritis-associated interstitial lung disease: Pathogenesis, risk stratification, and management.
Gao R, Liu S, Song L
Respiratory medicine 2026; (261()):109066 doi:10.1016/j.rmed.2026.109066.
PMID: 42521038 - 4
Predictive factors of mortality in rheumatoid arthritis-associated interstitial lung disease analysed by modified HRCT classification of idiopathic pulmonary fibrosis according to the 2018 ATS/ERS/JRS/ALAT criteria.
Yamakawa H, Sato S, Tsumiyama E, et al.
Journal of thoracic disease 2019; (11(12)):5247-5257 doi:10.21037/jtd.2019.11.73.
PMID: 32030242 - 5
Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.
Qiu M, Jiang J, Nian X, et al.
Respiratory research 2021; (22(1)):264 doi:10.1186/s12931-021-01856-z.
PMID: 34635095 - 6
Treatment of rheumatoid arthritis-associated interstitial lung disease: An appraisal of the 2023 ACR/CHEST guideline.
Saavedra AA, Mueller KT, Kowalski EN, et al.
Current treatment options in rheumatology 2024; (10(4)):43-60 doi:10.1007/s40674-024-00217-3.
PMID: 39822854 - 7
Risk factors for rheumatoid arthritis-associated interstitial lung disease: a retrospective study.
Ben Tekaya A, Mokaddem S, Athimini S, et al.
Multidisciplinary respiratory medicine 2022; (17()):877 doi:10.4081/mrm.2022.877.
PMID: 36507116 - 8
Traction Bronchiectasis/Bronchiolectasis is Associated with Interstitial Lung Abnormality Mortality.
Hida T, Nishino M, Hino T, et al.
European journal of radiology 2020; (129()):109073 doi:10.1016/j.ejrad.2020.109073.
PMID: 32480316 - 9
Functional, radiological and survival outcomes in rheumatoid arthritis-associated interstitial lung disease: 24-month results from the BERTHA prospective cohort.
Kawano-Dourado L, Bonfiglioli K, Ribeiro ACM, et al.
BMJ open respiratory research 2026; (13(1)) doi:10.1136/bmjresp-2025-003973.
PMID: 41760357 - 10
Several high-resolution computed tomography findings associate with survival and clinical features in rheumatoid arthritis-associated interstitial lung disease.
Nurmi HM, Kettunen HP, Suoranta SK, et al.
Respiratory medicine 2018; (134()):24-30 doi:10.1016/j.rmed.2017.11.013.
PMID: 29413504 - 11
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases.
Johnson SR, Bernstein EJ, Bolster MB, et al.
Arthritis & rheumatology (Hoboken, N.J.) 2024; (76(8)):1201-1213 doi:10.1002/art.42860.
PMID: 38973714 - 12
High-resolution computed tomography of the lung in patients with rheumatoid arthritis: Prevalence of interstitial lung disease involvement and determinants of abnormalities.
Salaffi F, Carotti M, Di Carlo M, et al.
Medicine 2019; (98(38)):e17088 doi:10.1097/MD.0000000000017088.
PMID: 31567944 - 13
Identification and management of interstitial lung disease associated with systemic sclerosis (SSc-ILD), rheumatoid arthritis (RA-ILD), and polymyositis/dermatomyositis (PM/DM-ILD): development of expert consensus-based clinical algorithms.
Kondoh Y, Bando M, Kawahito Y, et al.
Expert review of respiratory medicine 2024; (18(6)):447-456 doi:10.1080/17476348.2024.2374910.
PMID: 38943279 - 14
Rheumatoid arthritis-associated interstitial lung disease: A review.
David M, Dieude P, Juge PA, et al.
Respiratory medicine and research 2026; (89()):101260 doi:10.1016/j.resmer.2026.101260.
PMID: 41903441 - 15
Management issues in rheumatoid arthritis-associated interstitial lung disease.
England BR, Hershberger D
Current opinion in rheumatology 2020; (32(3)):255-263 doi:10.1097/BOR.0000000000000703.
PMID: 32141954 - 16
Diffuse lung involvement in rheumatoid arthritis: a respiratory physician's perspective.
Huang H, Chen R, Shao C, et al.
Chinese medical journal 2023; (136(3)):280-286 doi:10.1097/CM9.0000000000002577.
PMID: 36689640
This page explains HRCT scans and breathing tests for informational purposes only and does not constitute medical advice. Your pulmonologist and rheumatologist should interpret your results and advise you about your care.